{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029978","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2024-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.995066+00:00","generated_at":"2026-05-31T13:26:11.591037+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bone Biologics raises $2.1M via exercise of warrants, issues new warrants for 1.56M shares","bullets":["Existing warrant holders exercised 781,251 shares at $2.43/share, yielding ~$2.1M gross proceeds.","Company issued new unregistered warrants to purchase 1,562,502 shares at $2.00/share (five-year and 18-month terms).","H.C. Wainwright acted as exclusive placement agent; fees include 7.0% cash fee and placement agent warrants.","Net proceeds to fund clinical trials, patent portfolio, and working capital.","Inducement transaction expected to close August 2, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029978","json":"https://secwatch.observer/filing/0001493152-24-029978.json","markdown":"https://secwatch.observer/filing/0001493152-24-029978.md","text":"https://secwatch.observer/filing/0001493152-24-029978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224029978/0001493152-24-029978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224029978/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:26:11.591037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}